Bli medlem
Bli medlem

Du är här


Bactiguard Holding AB (publ): Bactiguard Holding AB's (publ) Annual General Meeting

At Bactiguard Holding AB's (publ) Annual General Meeting on May 19,
the following resolutions were made:

· The Annual General Meeting adopted the income statement and
balance sheet for 2015.

· It was decided that no dividend for the financial year 2015 will
be paid and that the company's loss (for the year) will be carried

· The Board of Directors and CEOs were discharged from liability for
the financial year 2015.

· The Annual General Meeting decided that an annual remuneration of
SEK 500 000 will be paid to the chairman of the Board and an amount
of SEK 200 000 to each of the other external directors. Furthermore
it was decided that an annual remuneration of SEK 100 000 will be
paid to each Chairman of the Audit Committee and Remuneration
Committee. No separate remuneration will be paid to the other
committee members. Provided that it is cost-neutral for the company,
remuneration may be invoiced through a wholly-owned company of a

· The Board members Stanley Brodén (chairman), Mia Arnhult, Peter
Hentschel and Christian Kinch were re-elected and Marie
Wickman-Chanteraeu was elected as new Board member. Stanley Brodén
was re-elected as the chairman of the Board.

· The Annual General Meeting decided to re-elect Deloitte AB, as
auditor. Remuneration to the auditors shall be paid according to
approved invoice.

· The Annual General Meeting adopted the Nomination Committee's
proposal for Instructions for the Nomination Committee.

· The proposed guidelines for compensation and other employment
terms for senior management were adopted.

This is information that Bactiguard Holding AB (publ) is required to
publish in compliance with the Swedish Securities Market Act and/or
the Financial Instruments Trading Act. The information was submitted
for publication on 19 May 2016, at 16.45.

For further information, please contact:
Ulrika Berglund, Head of External Affairs, Cell & Text: +46 708 800

About Bactiguard
Bactiguard is a Swedish medtech company with a global presence,
offering a solution that prevents healthcare associated infections
caused by medical devices. By preventing infections, we contribute to
a reduced use of antibiotics and the spread of multi-resistant
bacteria, which is a growing problem worldwide. We save lives,
increase patient safety and significantly reduce the cost for the
healthcare and society. Our technology is well-proven, safe and
tissue friendly and consist of a thin layer of noble metals that
prevents bacterial growth. The coating can be applied on almost all
medical devices. Bactiguard-coated urinary catheters are market
leading in the US and Japan and the company has also its own product
portfolio consisting of Foley catheters, central venous catheters and
endotracheal tubes. Bactiguard is a growth company, focused on
markets in Europe, Middle East, Asia and Latin America. The company
has about 60 employees worldwide, mainly at the headquarters in
Stockholm and the production facility in Malaysia and is listed on
Nasdaq Stockholm. Read more about Bactiguard at


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.